Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
Cascinu S, Baldelli AM, Catalano V, Giordani P, Beretta GD, Silva RR, Gasparini G, Mari D, Maisano R, Salvagni S, Barni S, Labianca R, Frontini L, Curti C, Catalano G. Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2002 Jan 21;86(2):213-7. doi: 10.1038/sj.bjc.6600046. Br J Cancer. 2002. PMID: 11870508 Free PMC article. Clinical Trial.
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S, Labianca R, Catalano V, Barni S, Ferraù F, Beretta GD, Frontini L, Foa P, Pancera G, Priolo D, Graziano F, Mare M, Catalano G. Cascinu S, et al. Among authors: beretta gd. Ann Oncol. 2003 Feb;14(2):205-8. doi: 10.1093/annonc/mdg061. Ann Oncol. 2003. PMID: 12562645 Free article. Clinical Trial.
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V; Italian Group for the Study of Digestive Tract Cancer (GISCAD). Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2004 Apr 19;90(8):1521-5. doi: 10.1038/sj.bjc.6601752. Br J Cancer. 2004. PMID: 15083179 Free PMC article. Clinical Trial.
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
Guglielmi A, Barni S, Zaniboni A, Pella N, Belvedere O, Beretta GD, Grossi F, Frontini L, Puglisi F, Labianca R, Sobrero A; Gruppo Italiano Studio Carcinomi Apparato Digerente. Guglielmi A, et al. Among authors: beretta gd. Br J Cancer. 2004 Oct 18;91(8):1428-33. doi: 10.1038/sj.bjc.6602176. Br J Cancer. 2004. PMID: 15381935 Free PMC article. Clinical Trial.
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.
Cascinu S, Berardi R, Salvagni S, Beretta GD, Catalano V, Pucci F, Sobrero A, Tagliaferri P, Labianca R, Scartozzi M, Crocicchio F, Mari E, Ardizzoni A. Cascinu S, et al. Among authors: beretta gd. Br J Cancer. 2008 Jan 15;98(1):71-6. doi: 10.1038/sj.bjc.6604121. Epub 2007 Dec 4. Br J Cancer. 2008. PMID: 18059397 Free PMC article. Clinical Trial.
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cascinu S, Galizia E, Labianca R, Ferraù F, Pucci F, Silva RR, Luppi G, Beretta GD, Berardi R, Scartozzi M. Cascinu S, et al. Among authors: beretta gd. Cancer Chemother Pharmacol. 2011 Jul;68(1):37-43. doi: 10.1007/s00280-010-1424-8. Epub 2010 Sep 7. Cancer Chemother Pharmacol. 2011. PMID: 20821330 Clinical Trial.
Individual tailored chemotherapy.
Beretta GD, Labianca R. Beretta GD, et al. Suppl Tumori. 2002 Nov-Dec;1(6):S25-7. doi: 10.1177/03008916020016s108. Suppl Tumori. 2002. PMID: 12658899 Review. No abstract available.
203 results